tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Mccarthy, 188 are a BUY (83.93%), 33 are a HOLD (14.73%), 3 are a SELL (1.34%).
Analyst Jason Mccarthy, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 37.71% that have a potential upside of 66.35% achieved within 216 days.
Jason Mccarthy’s has documented 434 price targets and ratings displayed on 66 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INDP, Indaptus Therapeutics at 13-Nov-2024.
Analyst best performing recommendations are on ANVS (ANNOVIS BIO ).
The best stock recommendation documented was for ANVS (ANNOVIS BIO ) at 5/13/2021. The price target of $45 was fulfilled within 8 days with a profit of $21.72 (93.3%) receiving and performance score of 116.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$15
$9.14 (155.97%)
$15
21 days ago
(31-Oct-2024)
0/5 (0%)
$8.59 (134.01%)
Buy
$18
$12.14 (207.17%)
$18
23 days ago
(29-Oct-2024)
1/6 (16.67%)
$11.43 (173.97%)
61
Hold
$6
$0.14 (2.39%)
$5
2 years 7 days ago
(14-Nov-2022)
2/3 (66.67%)
$1.85 (44.58%)
257
Buy
$75
$70.79 (1681.47%)
$50
4 years 10 days ago
(11-Nov-2020)
2/3 (66.67%)
$45.92 (117.11%)
101
Buy
$22
4 years 6 months 13 days ago
(08-May-2020)
1/3 (33.33%)
$-59.25 (-72.92%)
820
Which stock is Jason Mccarthy is most bullish on?
Which stock is Jason Mccarthy is most reserved on?
What Year was the first public recommendation made by Jason Mccarthy?
